Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buphenyl for Fatty Acid-Induced Insulin Impairment
NCT00533559Phase 4Completed
- Sponsor
- University Health Network
- Start
- Sep 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium phenylbutyrate in insulin resistance (IR), type 2 diabetes mellitus (T2DM), sponsored by University Health Network. Started Sep 2007; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
insulin resistance (IR)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00533559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533559.